These 6 words from the CMO of Moderna could mean billions in 2022
Modern (NASDAQ: MRNA) is already on its way to billion-dollar revenue this year. The company said in February that pre-purchase agreements for its coronavirus vaccine translated into $ 18.4 billion…
